MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis

Chemoresistance is one of the causes of poor prognosis in pancreatic cancer patients. However, the mechanisms of resistance remain unclear. Here we screened miRNAs associated with drug resistance in pancreatic cancer, and identified a panel of miRNAs dysregulated in gemcitabine-resistance pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jianwei, Wang, Tianxiao, Cao, Zhe, Huang, Hua, Li, Jian, Liu, Wenjing, Liu, Shanglong, You, Lei, Zhou, Li, Zhang, Taiping, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196178/
https://www.ncbi.nlm.nih.gov/pubmed/25149530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196178/
https://www.ncbi.nlm.nih.gov/pubmed/25149530

Ejemplares similares